Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.04B |
| 2 |
AbbVie
ABBV
|
+$511M |
| 3 |
GE Vernova
GEV
|
+$199M |
| 4 |
Bank of America
BAC
|
+$193M |
| 5 |
Hilton Worldwide
HLT
|
+$169M |
Top Sells
| 1 |
Merck
MRK
|
+$634M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$393M |
| 3 |
Palantir
PLTR
|
+$294M |
| 4 |
Applovin
APP
|
+$255M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$215M |
Sector Composition
| 1 | Technology | 16.55% |
| 2 | Financials | 9.27% |
| 3 | Industrials | 6.89% |
| 4 | Healthcare | 6.26% |
| 5 | Consumer Discretionary | 6.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
6101
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.82B
| $3.94K | ﹤0.01% |
+235
| New | +$3.94K |
|
6102
PLAYSTUDIOS Inc
MYPS
$121M
| $3.93K | ﹤0.01% |
+3,000
| New | +$3.93K |
|
6103
Alpha Tau Medical
DRTS
$314M
| $3.87K | ﹤0.01% |
+1,240
| New | +$3.87K |
|
6104
Prime Medicine
PRME
$734M
| $3.86K | ﹤0.01% |
+1,564
| New | +$3.86K |
|
|
USAS
6105
Americas Gold and Silver
USAS
$736M
| $3.85K | ﹤0.01% |
+1,905
| New | +$3.85K |
|
6106
Laser Photonics
LASE
$31.8M
| $3.84K | ﹤0.01% |
+1,427
| New | +$3.84K |
|
6107
DoubleVerify
DV
$2.53B
| $3.83K | ﹤0.01% |
+256
| New | +$3.83K |
|
6108
NEOS Enhanced Income 1-3 Month T-Bill ETF
CSHI
$620M
| $3.83K | ﹤0.01% |
+77
| New | +$3.83K |
|
6109
Lesaka Technologies
LSAK
$369M
| $3.82K | ﹤0.01% |
+850
| New | +$3.82K |
|
6110
Shuttle Pharmaceuticals
SHPH
$3.59M
| $3.77K | ﹤0.01% |
+1,000
| New | +$3.77K |
|
6111
Evolent Health
EVH
$1.12B
| $3.72K | ﹤0.01% |
+330
| New | +$3.72K |
|
6112
BondBloxx Bloomberg Two Year Target Duration US Treasury ETF
XTWO
$138M
| $3.72K | ﹤0.01% |
+75
| New | +$3.72K |
|
6113
Enviri
NVRI
$938M
| $3.71K | ﹤0.01% |
+427
| New | +$3.71K |
|
6114
SITE Centers
SITC
$495M
| $3.68K | ﹤0.01% |
+325
| New | +$3.68K |
|
6115
Full House Resorts
FLL
$120M
| $3.66K | ﹤0.01% |
+1,000
| New | +$3.66K |
|
6116
BARK
BARK
$151M
| $3.64K | ﹤0.01% |
+4,140
| New | +$3.64K |
|
6117
Satellogic
SATL
$393M
| $3.62K | ﹤0.01% |
+1,000
| New | +$3.62K |
|
6118
Aligos Therapeutics
ALGS
$77.2M
| $3.61K | ﹤0.01% |
+500
| New | +$3.61K |
|
|
IMDX
6119
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$71.3M
| $3.59K | ﹤0.01% |
+1,189
| New | +$3.59K |
|
6120
Alto Ingredients
ALTO
$88.2M
| $3.59K | ﹤0.01% |
+3,119
| New | +$3.59K |
|
6121
BioCardia
BCDA
$12.2M
| $3.58K | ﹤0.01% |
+1,838
| New | +$3.58K |
|
6122
VinFast Auto
VFS
$7.53B
| $3.57K | ﹤0.01% |
+1,000
| New | +$3.57K |
|
6123
Southside Bancshares
SBSI
$926M
| $3.56K | ﹤0.01% |
121
-9,216
| -99% | -$271K |
|
6124
Pyxis Oncology
PYXS
$113M
| $3.55K | ﹤0.01% |
+3,231
| New | +$3.55K |
|
6125
GEE Group
JOB
$20.8M
| $3.54K | ﹤0.01% |
18,000
| – | – |
|